Form 4 for INSM INSMED Inc
Accepted 2023-05-17 00:00:00 ET · period of report 2023-05-15 · accession 0001628280-23-018700 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-17 | 2023-05-15+ | INSM | Wise John Drayton | Chief Commercial Off | S - Sale | $18.44 | -2,887 | 106.0K | -3% | -$53.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-15 | S | D | 593 | $19.29 | 108,341 | D | — | — | (F2) This is the weighted average sales price representing 593 shares sold at prices ranging from $19.29 to $19.30 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 2 | Common | Common Stock | 2023-05-16 | S | D | 381 | $18.44 | 107,960 | D | — | — | |
| 3 | Common | Common Stock | 2023-05-17 | S | D | 1,913 | $18.17 | 106,047 | D | — | — |